130 related articles for article (PubMed ID: 16630220)
1. Recovery of normal autologous myelopoiesis after graft rejection following allogeneic bone marrow transplant for agnogenic myeloid metaplasia.
Alkindi S; Deeg JH; Flowers ME
Clin Lab Haematol; 2006 Apr; 28(2):134-7. PubMed ID: 16630220
[TBL] [Abstract][Full Text] [Related]
2. Successful allogeneic bone marrow transplantation for agnogenic myeloid metaplasia in a 3-year-old boy.
Rossbach HC; Grana NH; Chamizo W; Barrios NJ; Barbosa JL
J Pediatr Hematol Oncol; 1996 May; 18(2):213-5. PubMed ID: 8846142
[TBL] [Abstract][Full Text] [Related]
3. Reversal of marrow fibrosis in agnogenic myeloid metaplasia by allogeneic peripheral blood stem cell transplantation.
Udomsakdi-Auewarakul C; Visuthisakchai S; Sangruchi T; Issaragrisil S
Asian Pac J Allergy Immunol; 2003 Jun; 21(2):121-6. PubMed ID: 14629130
[TBL] [Abstract][Full Text] [Related]
4. [Allogeneic bone marrow transplantation for primary myelofibrosis after splenectomy].
Sakashita C; Akiyama H; Mori S; Ohashi K; Sakamaki H
Rinsho Ketsueki; 2000 Mar; 41(3):206-11. PubMed ID: 10774249
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation for primary myelofibrosis.
Singhal S; Powles R; Treleaven J; Pollard C; Lumley H; Mehta J
Bone Marrow Transplant; 1995 Dec; 16(6):743-6. PubMed ID: 8750263
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study.
Guardiola P; Anderson JE; Bandini G; Cervantes F; Runde V; Arcese W; Bacigalupo A; Przepiorka D; O'Donnell MR; Polchi P; Buzyn A; Sutton L; Cazals-Hatem D; Sale G; de Witte T; Deeg HJ; Gluckman E
Blood; 1999 May; 93(9):2831-8. PubMed ID: 10216077
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation for postpolycythemic myeloid metaplasia with myelofibrosis: a case report.
de Revel T; Giraudier S; Nedellec G; Joussemet M; Bourin P; Schill H; Gaillard JF; Auzanneau G
Bone Marrow Transplant; 1995 Jul; 16(1):187-9. PubMed ID: 7581121
[TBL] [Abstract][Full Text] [Related]
8. Acute megakaryoblastic leukemia with massive myelofibrosis: complete remission and reversal of marrow fibrosis with allogeneic bone marrow transplantation as the only treatment.
Bullorsky EO; Shanley CM; Stemmelin G; Venditti J; Lajous JR
Bone Marrow Transplant; 1990 Dec; 6(6):449-52. PubMed ID: 2097015
[TBL] [Abstract][Full Text] [Related]
9. Agnogenic myeloid metaplasia with pulmonary hematopoiesis.
Boula A; Mantadakis E; Xilouri I; Foudoulakis A; Samonis G
Hematology; 2005 Dec; 10(6):501-3. PubMed ID: 16321815
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic bone marrow transplantation as primary treatment in acute myelofibrosis].
Maruta A; Matsuzaki M; Kanamori H; Fukawa H; Kodama F; Kobayashi S; Seki K; Yamaguchi M; Murata T; Hashimoto Y
Rinsho Ketsueki; 1989 Jun; 30(6):904-9. PubMed ID: 2795903
[TBL] [Abstract][Full Text] [Related]
11. Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation.
Fouillard L; Deconinck E; Tiberghien P; Deschaseaux ML; Solary E; Mugneret F; Brion A; Herve P; Cahn JY
Bone Marrow Transplant; 1998 May; 21(9):943-6. PubMed ID: 9613789
[TBL] [Abstract][Full Text] [Related]
12. Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays.
Jones LC; Tefferi A; Vuong PT; Desmond JC; Hofmann WK; Koeffler HP
Stem Cells; 2005 May; 23(5):631-7. PubMed ID: 15849170
[TBL] [Abstract][Full Text] [Related]
13. Prolonged remission of accelerated phase Philadelphia chromosome negative chronic myeloid leukemia following autologous recovery of normal hematopoietic elements after busulfan/cyclophosphamide and allogeneic marrow transplantation.
Kapoor N; Keever CA; Hsu SH; Copelan EA; Tutschka PJ
Bone Marrow Transplant; 1992 Feb; 9(2):143-5. PubMed ID: 1349249
[TBL] [Abstract][Full Text] [Related]
14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
16. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic cord hematopoietic stem cell transplantation in an infant with primary myelofibrosis.
Shaikh F; Naithani R; Kirby-Allen M; Doyle J
J Pediatr Hematol Oncol; 2012 Jul; 34(5):e199-201. PubMed ID: 22246154
[TBL] [Abstract][Full Text] [Related]
18. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
19. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
Hummel S; Wilms D; Vitacolonna M; Zöller M
J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
[TBL] [Abstract][Full Text] [Related]
20. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.
Sykes M; Preffer F; McAfee S; Saidman SL; Weymouth D; Andrews DM; Colby C; Sackstein R; Sachs DH; Spitzer TR
Lancet; 1999 May; 353(9166):1755-9. PubMed ID: 10347989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
